 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/18/2024 |
$227.78 |
$227.90 |
$220.74 |
$222.26 |
268.80K | | 04/19/2024 |
$221.85 |
$224.68 |
$206.03 |
$212.04 |
625.20K | | 04/22/2024 |
$205.19 |
$217.14 |
$197.43 |
$213.49 |
727.30K | | 04/23/2024 |
$212.82 |
$225.66 |
$210.10 |
$218.38 |
409.50K | | 04/24/2024 |
$218.08 |
$220.00 |
$204.16 |
$204.65 |
575.50K |
|
|
| Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Co.'s primary product candidate, resmetirom, is being developed as a once-daily oral pill to treat several disease states, including non-alcoholic steatohepatitis, or NASH. Co. has initiated MAESTRO-NASH, a Phase 3 trial in NASH with its once daily, oral thyroid hormone receptor beta selective agonist, resmetirom. Co. has opened for enrollment MAESTRO-NAFLD-1, a Phase 3 clinical study of patients with biopsy-confirmed or presumed NASH recruited from sites in the U.S. | |
|
Madrigal Pharmaceuticals (MDGL) has the following price history information. Looking back at MDGL historical stock prices for the last five trading days, on April 18, 2024, MDGL opened at $227.78, traded as high as $227.90 and as low as $220.74, and closed at $222.26. Trading volume was a total of 268.80K shares. On April 19, 2024, MDGL opened at $221.85, traded as high as $224.68 and as low as $206.03, and closed at $212.04. Trading volume was a total of 625.20K shares. On April 22, 2024, MDGL opened at $205.19, traded as high as $217.14 and as low as $197.43, and closed at $213.49. Trading volume was a total of 727.30K shares. On April 23, 2024, MDGL opened at $212.82, traded as high as $225.66 and as low as $210.10, and closed at $218.38. Trading volume was a total of 409.50K shares. On April 24, 2024, MDGL opened at $218.08, traded as high as $220.00 and as low as $204.16, and closed at $204.65. Trading volume was a total of 575.50K shares.
MDGL Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Madrigal Pharmaceuticals shares, starting with a $10,000 purchase of MDGL, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/28/2014 |
|
| End date: |
04/24/2024 |
|
| Start price/share: |
$139.65 |
|
| End price/share: |
$204.65 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
46.54% |
|
| Average Annual Total Return: |
3.90% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$14,659.19 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/18/2024 | $222.26 | | 04/19/2024 | $212.04 | | 04/22/2024 | $213.49 | | 04/23/2024 | $218.38 | | 04/24/2024 | $204.65 |
|
|
Free MDGL Email Alerts:
